United States · Bill · S
S. 1286 (117th)
Ensuring Compliance Against Drug Diversion Act of 2021
Introduced
21 April 2021
Last action
—
Status
Read twice and referred to the Committee on the Judiciary.
Sponsors
—
Subjects
Discovery layer
Source updated
10 August 2026
Summary
Ensuring Compliance Against Drug Diversion Act of 2021 This bill provides statutory authority for certain regulations governing the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances. It terminates the registration of individuals and entities when they die, cease legal existence, discontinue business, or surrender such registration. It sets forth notification requirements, as well as conditions for transferring or assigning a registration.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 21 April 2021
Introduced in Senate (PDF)
Introduced in Senate · EN · 21 April 2021
Introduced in Senate
summary · EN · 21 April 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/senate-bill/1286
- Open data entity: https://api.congress.gov/v3/bill/117/s/1286